Cargando…

Burden of brain and other central nervous system cancer in China, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019

OBJECTIVE: To evaluate the trends in disease burden and the epidemiological features of central nervous system (CNS) cancer in China from 1990 to 2019. DESIGN: A population-based observational study. SETTING: The incidence, prevalence, death and disability-adjusted life years (DALYs) due to CNS canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Xinran, Song, Zongbin, Zhang, Fan, Liu, Zhuoyi, Long, Wenyong, Long, Zheng, Zhou, Maigeng, Wang, E, Yin, Peng, Zhu, Maoen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297202/
https://www.ncbi.nlm.nih.gov/pubmed/35851020
http://dx.doi.org/10.1136/bmjopen-2021-059699
_version_ 1784750424678465536
author Hou, Xinran
Song, Zongbin
Zhang, Fan
Liu, Zhuoyi
Long, Wenyong
Long, Zheng
Zhou, Maigeng
Wang, E
Yin, Peng
Zhu, Maoen
author_facet Hou, Xinran
Song, Zongbin
Zhang, Fan
Liu, Zhuoyi
Long, Wenyong
Long, Zheng
Zhou, Maigeng
Wang, E
Yin, Peng
Zhu, Maoen
author_sort Hou, Xinran
collection PubMed
description OBJECTIVE: To evaluate the trends in disease burden and the epidemiological features of central nervous system (CNS) cancer in China from 1990 to 2019. DESIGN: A population-based observational study. SETTING: The incidence, prevalence, death and disability-adjusted life years (DALYs) due to CNS cancer in China, stratified by sex, age and provincial region, were collected from the Global Burden of Disease Study 2019. PARTICIPANTS: Data were publicly available and individuals were not involved. RESULTS: In 2019, the incident cases of CNS cancer in China were 347 992 (95% UI 262 084–388 896), and the age-standardised rate (ASR) of incidence was 5.69 (95% UI 4.36–6.78) per 100 000 person-years increased by 27.9% compared with that in 1990; meanwhile, CNS cancer caused 63 527 (95% UI 47 793–76 948) deaths in China in 2019, and the ASR of death was 3.5 (95% UI 2.62–4.21) per 100 000 person-years decreased by 9.6%. The ASRs of incidence and prevalence of CNS cancer in China increased more rapidly than the global average; meanwhile, the ASRs of DALYs owing to CNS cancer declined more rapidly. The burden of CNS cancer showed no significant differences between men and women, but was more pronounced in early childhood and old adulthood. The ASRs of incidence and prevalence were higher in high-income provinces, confirmed by the positive correlation with Sociodemographic Index (SDI), with correlation coefficient r of 0.322 and 0.767, respectively (both p<0.0001). However, the ASRs of death and DALYs demonstrated a negative correlation with SDI, with r of -‍0.319 and −0.642, respectively (both p<0.0001). CONCLUSIONS: From a global perspective, China has been bearing a substantial burden of CNS cancer. More attention should be paid to children and elderly populations for CNS cancer. The disease burden varied significantly at the subnational level of China, which was associated with socioeconomic development.
format Online
Article
Text
id pubmed-9297202
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-92972022022-08-09 Burden of brain and other central nervous system cancer in China, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019 Hou, Xinran Song, Zongbin Zhang, Fan Liu, Zhuoyi Long, Wenyong Long, Zheng Zhou, Maigeng Wang, E Yin, Peng Zhu, Maoen BMJ Open Epidemiology OBJECTIVE: To evaluate the trends in disease burden and the epidemiological features of central nervous system (CNS) cancer in China from 1990 to 2019. DESIGN: A population-based observational study. SETTING: The incidence, prevalence, death and disability-adjusted life years (DALYs) due to CNS cancer in China, stratified by sex, age and provincial region, were collected from the Global Burden of Disease Study 2019. PARTICIPANTS: Data were publicly available and individuals were not involved. RESULTS: In 2019, the incident cases of CNS cancer in China were 347 992 (95% UI 262 084–388 896), and the age-standardised rate (ASR) of incidence was 5.69 (95% UI 4.36–6.78) per 100 000 person-years increased by 27.9% compared with that in 1990; meanwhile, CNS cancer caused 63 527 (95% UI 47 793–76 948) deaths in China in 2019, and the ASR of death was 3.5 (95% UI 2.62–4.21) per 100 000 person-years decreased by 9.6%. The ASRs of incidence and prevalence of CNS cancer in China increased more rapidly than the global average; meanwhile, the ASRs of DALYs owing to CNS cancer declined more rapidly. The burden of CNS cancer showed no significant differences between men and women, but was more pronounced in early childhood and old adulthood. The ASRs of incidence and prevalence were higher in high-income provinces, confirmed by the positive correlation with Sociodemographic Index (SDI), with correlation coefficient r of 0.322 and 0.767, respectively (both p<0.0001). However, the ASRs of death and DALYs demonstrated a negative correlation with SDI, with r of -‍0.319 and −0.642, respectively (both p<0.0001). CONCLUSIONS: From a global perspective, China has been bearing a substantial burden of CNS cancer. More attention should be paid to children and elderly populations for CNS cancer. The disease burden varied significantly at the subnational level of China, which was associated with socioeconomic development. BMJ Publishing Group 2022-07-18 /pmc/articles/PMC9297202/ /pubmed/35851020 http://dx.doi.org/10.1136/bmjopen-2021-059699 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Hou, Xinran
Song, Zongbin
Zhang, Fan
Liu, Zhuoyi
Long, Wenyong
Long, Zheng
Zhou, Maigeng
Wang, E
Yin, Peng
Zhu, Maoen
Burden of brain and other central nervous system cancer in China, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019
title Burden of brain and other central nervous system cancer in China, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019
title_full Burden of brain and other central nervous system cancer in China, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019
title_fullStr Burden of brain and other central nervous system cancer in China, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019
title_full_unstemmed Burden of brain and other central nervous system cancer in China, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019
title_short Burden of brain and other central nervous system cancer in China, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019
title_sort burden of brain and other central nervous system cancer in china, 1990–2019: a systematic analysis of observational data from the global burden of disease study 2019
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297202/
https://www.ncbi.nlm.nih.gov/pubmed/35851020
http://dx.doi.org/10.1136/bmjopen-2021-059699
work_keys_str_mv AT houxinran burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT songzongbin burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT zhangfan burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT liuzhuoyi burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT longwenyong burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT longzheng burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT zhoumaigeng burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT wange burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT yinpeng burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019
AT zhumaoen burdenofbrainandothercentralnervoussystemcancerinchina19902019asystematicanalysisofobservationaldatafromtheglobalburdenofdiseasestudy2019